Inspirata

Inspirata

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $38M

Overview

Inspirata, founded in 2012 and headquartered in Tampa, Florida, is a private company specializing in oncology-focused digital pathology and AI-driven data management solutions. It offers an end-to-end platform that automates cancer case finding, data abstraction, and reporting, serving over 270 hospitals and processing 30+ million reports per year. Through an exclusive partnership with ONCO, Inspirata delivers a unified system aimed at improving regulatory compliance, clinical trial accrual, and patient navigation. The company is revenue-generating, operating in the commercial stage with a services and platform business model.

Oncology

Technology Platform

AI and NLP engine for automated mining of clinical documents to identify reportable cancer cases and extract data points; integrated end-to-end cancer registry and clinical trial matching platform developed in partnership with ONCO.

Funding History

2
Total raised:$38M
Series B$23M
Series A$15M

Opportunities

The growing global cancer burden and shift to value-based care drive demand for automated data management.
Expansion of its AI platform into life sciences research using aggregated, real-world data presents a significant new revenue stream.
Deepening integrations and upselling additional modules (e.g., trial matching) within its existing large hospital network offers low-cost growth.

Risk Factors

Faces intense competition from large EHR vendors and specialized startups.
Must continuously adapt its AI models and software to evolving clinical reporting standards and data privacy regulations.
Complex hospital sales cycles and technical integrations pose execution risks.

Competitive Landscape

Inspirata competes with large EHR providers (e.g., Epic, Oracle Cerner) offering oncology modules, specialized cancer registry software vendors, and a growing number of AI startups focused on clinical NLP or digital pathology. Its exclusive partnership with ONCO and 100% oncology focus are key differentiators in a fragmented market.